In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

No Wrinkles in the US Market for Non-Invasive Aesthetic Devices

This article was originally published in Start Up

Executive Summary

Aesthetic device sales were $520 million in 2006, according to US Markets for Energy-Based Aesthetics and Therapies, a report recently published by the Medtech Insight division of Windhover Information Inc., and are expected to reach approximately $1.2 billion in the year 2011. In addition to cultural factors, the minimally invasive nature of the new devices themselves, which result in lower treatment costs and shorter healing times, is helping to drive growth in the industry.

You may also be interested in...



Start-Up News November 2007

Noteworthy news from medtech start-ups, including Actuality Medical's dynamic adaptive therapy for brachytherapy and other indications; WaveBlend's new platform for aesthetic treatments; new spine products from US Spine.

Beauty: In the Eye of the Stakeholder

A $12-billion market and growing, the field of aesthetic medicine has exploded with new treatments and techniques for improving and restoring the quality, health and appearance of aging skin. Techniques such as tissue tightening, skin resurfacing, cellulite treatments, dermal augmentation, and fat removal are just some of the new advancements in aesthetic medicine that were highlighted at the 2007 American Academy of Dermatology meeting.

Scratch-Free Skin Resurfacing

In the red-hot skin cosmetic surgery market, Reliant Technologies and Rhytec aim for the market gap between ablative laser skin resurfacing and gentler, but less effective technologies. Their devices match the resurfacing and regenerative power of CO2 lasers, but with less tissue destruction and therefore shorter procedures and faster recoveries.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT037514

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel